| In millions, except per share items | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| | 8-K | 8-K | 10-Q | 10-Q | 10-K | 8-K | 10-Q | 10-Q |
| Interest income: |
| Interest income on loans | | | 117.9 | 110.0 | | | 214.0 | 213.9 |
| Interest income on investments | | | 17.8 | 16.1 | | | 32.3 | 35.5 |
| | | | 136.3 | 126.3 | | | 246.6 | 249.6 |
| Interest on borrowings | | | 5.8 | 4.7 | | | 10.7 | 11.5 |
| Total interest expense | | | 21.7 | 20.7 | | | 55.0 | 61.7 |
| Net interest income | 266.7 | 240.3 | 222.2 | 213.2 | 205.1 | 198.0 | 191.5 | 187.9 |
| Provision for loan losses | | | | -31.5 | -21.5 | | 13.0 | |
| Net interest income after provision for loan losses | 276.7 | 266.8 | 248.7 | 244.7 | 226.6 | 203.0 | 178.5 | 121.3 |
| Other non-interest income | 67.3 | 120.2 | 117.7 | 120.5 | 120.6 | 54.8 | 61.7 | 65.7 |
| Total non-interest income | 67.3 | 120.2 | 117.7 | 120.5 | 120.6 | 54.8 | 61.7 | 65.7 |
| Non-interest expenses | | | 123.1 | 111.9 | | | 191.9 | 177.5 |
| Pre-tax income before non-recurring items | 75.0 | 152.8 | 148.9 | 156.0 | 151.3 | 63.3 | 48.4 | 9.5 |
| Non-recurring items | | | 6.8 | 4.0 | | | | |
| Pre-tax income | 68.2 | 146.0 | 142.1 | 152.0 | 151.3 | 63.3 | 48.4 | 9.5 |
| Income taxes | 6.0 | 39.7 | 39.7 | 42.1 | 41.8 | 8.1 | 8.6 | 0.1 |
| Tax rate | 8.8% | 27.2% | 28.0% | 27.7% | 27.6% | 12.9% | 17.8% | 1.5% |
| Minority interest | | | -3.8 | -4.5 | -3.4 | | -0.8 | |
| Net income | 63.3 | 110.0 | 106.1 | 114.4 | 112.9 | 55.9 | 40.6 | 9.4 |
| Net margin | 18.4% | 28.4% | 29.0% | 31.3% | 32.5% | 21.7% | 16.9% | 5.0% |
| |
| Basic EPS | $1.87 | $3.16 | $2.97 | $3.12 | $3.03 | $1.45 | $1.03 | $0.23 |
| Diluted EPS | $1.85 | $3.14 | $2.95 | $3.10 | $3.00 | $1.45 | $1.02 | $0.23 |
| |
| Shares outstanding (basic) | 33.9 | 34.8 | 35.7 | 36.6 | 37.3 | 38.5 | 39.6 | 40.7 |
| Shares outstanding (diluted) | 34.1 | 35.1 | 36.0 | 37.0 | 37.6 | 38.7 | 39.8 | 40.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |